Related by context. Frequent words. (Click for all words.) 66 preclinical efficacy 66 Phase IIb clinical trials 65 GRNVAC1 64 GVAX R 63 dose escalation clinical 62 phase Ib 62 Phase Ib II 62 systemically administered 61 refractory chronic lymphocytic 61 IND submission 61 nonclinical studies 61 BiTE R 60 BrachySil 60 FavId 60 Initiates Phase II 60 R sorafenib tablets 60 pharmacodynamic effects 60 preclinical toxicology 60 HGS ETR2 60 Panzem R 60 Phase Ia 60 Protexia R 60 CEQ# 60 pharmacokinetics PK 60 Pivotal Phase III 60 Onalta 60 pharmacokinetic studies 60 SAR# [004] 59 MVA BN R 59 Trofex 59 Phase Ib clinical 59 Initiate Phase 59 PEG SN# 59 IND enabling 59 REGN# 59 Phase 2b clinical trials 59 Fast Track Status 59 motesanib 58 Phase IIa trial 58 multicenter Phase 58 Phase III Clinical Trial 58 AZX# 58 Presents Positive 58 Chemophase 58 Hematide TM 58 KNS # 58 Lymphoseek ® 58 Phase 2a trial 58 ICA # 58 forodesine 58 thymalfasin 58 NEUMUNE 58 ZFP Therapeutic 58 Ixempra 58 Tarvacin TM 58 Meets Primary Endpoint 58 phase IIb clinical 58 Tesetaxel 58 Corlux 57 Azedra 57 clevudine 57 SUCCEED trial 57 Factor VIIa 57 Alzhemed TM 57 Receives Orphan Drug Designation 57 Prulifloxacin 57 FACTIVE R gemifloxacin 57 AEG# 57 Genasense ® oblimersen 57 liposomal formulation 57 Allovectin 7 R 57 OncoVEX GM CSF 57 Daclizumab 57 Omigard 57 ongoing Phase 1b 57 DXL# 57 vivo efficacy 57 Phase Ib IIa 57 RH1 57 polyclonal 57 KRN# 57 Phase IIa trials 57 safety tolerability pharmacokinetics 57 Phase 1b trial 57 Anthim 57 Soliris TM eculizumab 57 isavuconazole 57 FDA Accepts 57 REP# 57 Clevudine 57 recurrent glioblastoma multiforme 57 PURE proprietary 57 Eculizumab 57 pharmacodynamics 57 efficacy tolerability 57 rhThrombin 57 MKC# 57 NeuVax 56 vismodegib 56 registrational trial 56 histone deacetylase HDAC inhibitor